Literature DB >> 7565646

ATP-dependent activation of phospholipase C by antigen, NECA, Na3VO4, and GTP-gamma-S in permeabilized RBL cell ghosts: differential augmentation by ATP, phosphoenolpyruvate and phosphocreatine.

S C Dreskin1.   

Abstract

Ghosts prepared from rat basophilic leukemia cells (RBL cell ghosts) and permeabilized with alpha-toxin from S. aureus are a simplified system for the study of Fc epsilon RI-mediated activation of phospholipase C (PLC). This activity is dependent upon ATP and magnesium, and is enhanced by the addition of another compound containing an energetic phosphate group, either phosphoenolpyruvate (PEP) or phosphocreatine (PCr). This effect appears to be specific for PEP and PCr in that other compounds with energetic phosphate bonds including fructose 1,6-bisphosphate and additional ATP are not effective. On the contrary, GTP-gamma-S, an activator of G proteins, activates PLC in the presence of ATP alone and this is not further enhanced by the addition of PEP. In addition to Fc epsilon RI and GTP-gamma-S, two other stimuli lead to enhanced activity of PLC in permeabilized RBL cell ghosts: 1) an inhibitor of tyrosine phosphatases (Na3VO4) and 2) an analog of adenosine (NECA). Data presented here extend previous results to show that activation of PLC by GTP-gamma-S is not enhanced either by the addition of PCr or by the addition of a more MgATP. Further new findings include the observations that activation of PLC by Na3VO4 is augmented by PEP and PCr in a fashion similar to that observed for Fc epsilon RI-mediated activation of PLC and that activation of PLC by NECA shows even more marked dependency on PEP than does activation by Fc epsilon RI or Na3VO4.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565646     DOI: 10.1007/BF00944609

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

Review 1.  Protein-tyrosine phosphorylation: an essential component of Fc epsilon RI signaling.

Authors:  M Benhamou; R P Siraganian
Journal:  Immunol Today       Date:  1992-06

2.  IgE receptor-mediated hydrolysis of phosphoinositides by cytoplasts from rat basophilic leukemia cells.

Authors:  S C Dreskin; V S Pribluda; H Metzger
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

Review 3.  Signal transduction by Fc receptors: the Fc epsilon RI case.

Authors:  M A Beaven; H Metzger
Journal:  Immunol Today       Date:  1993-05

4.  Orthovanadate induces translocation of phospholipase C-gamma 1 and -gamma 2 in permeabilized mast cells.

Authors:  T P Atkinson; C W Lee; S G Rhee; R J Hohman
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

5.  Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases.

Authors:  E Eiseman; J B Bolen
Journal:  Nature       Date:  1992-01-02       Impact factor: 49.962

6.  Isoprenoid pathway activity is required for IgE receptor-mediated, tyrosine kinase-coupled transmembrane signaling in permeabilized RBL-2H3 rat basophilic leukemia cells.

Authors:  G G Deanin; J R Pfeiffer; J L Cutts; M L Fore; J M Oliver
Journal:  Cell Regul       Date:  1991-08

7.  Src homology 2 domains of Syk and Lyn bind to tyrosine-phosphorylated subunits of the high affinity IgE receptor.

Authors:  H Kihara; R P Siraganian
Journal:  J Biol Chem       Date:  1994-09-02       Impact factor: 5.157

8.  Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high affinity immunoglobulin E receptor.

Authors:  M H Jouvin; M Adamczewski; R Numerof; O Letourneur; A Vallé; J P Kinet
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

9.  Functional coupling between sarcoplasmic-reticulum-bound creatine kinase and Ca(2+)-ATPase.

Authors:  P Korge; S K Byrd; K B Campbell
Journal:  Eur J Biochem       Date:  1993-05-01

10.  Comparison of endogenous and exogenous sources of ATP in fueling Ca2+ uptake in smooth muscle plasma membrane vesicles.

Authors:  C D Hardin; L Raeymaekers; R J Paul
Journal:  J Gen Physiol       Date:  1992-01       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.